Prenatal treatment of congenital adrenal hyperplasia-not standard of care - PubMed (original) (raw)

Review

Prenatal treatment of congenital adrenal hyperplasia-not standard of care

Selma Feldman Witchel et al. J Genet Couns. 2012 Oct.

Abstract

Congenital adrenal hyperplasia (CAH) due to steroid 21-hydroxylase deficiency is a common autosomal recessive disorder due to mutations in the CYP21A2 gene. Since genetic counselors play a crucial role in educating families about inherited disorders, they need to have thorough knowledge regarding the pathophysiology of CAH especially the effects on the fetus, the complex genetics of this disorder, and the controversies surrounding experimental prenatal dexamethasone treatment. Affected female fetuses may have varying degree of virilization of the external genitalia. Starting in the 1980's, supraphysiologic glucocorticoid treatment was used to decrease the virilization of the external genitalia of affected female fetuses. However, recent clinical observations, animal studies and greater awareness of the details of human fetal adrenal physiology raise concerns regarding the safety of this prenatal treatment. We review the pathophysiology of CAH, the safety and ethical considerations of prenatal dexamethasone treatment and the views of multiple medical societies that conclude that this experimental therapy should only be done in prospective trials approved by ethical review boards.

PubMed Disclaimer

Similar articles

• Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
  Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI. Carlson AD, et al. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):19-29. doi: 10.1016/s0960-0760(99)00059-x. J Steroid Biochem Mol Biol. 1999. PMID: 10418977 Review.
• Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment.
  Nimkarn S, New MI. Nimkarn S, et al. Ann N Y Acad Sci. 2010 Mar;1192:5-11. doi: 10.1111/j.1749-6632.2009.05225.x. Ann N Y Acad Sci. 2010. PMID: 20392211 Review.
• Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  Nimkarn S, New MI. Nimkarn S, et al. Mol Cell Endocrinol. 2009 Mar 5;300(1-2):192-6. doi: 10.1016/j.mce.2008.11.027. Epub 2008 Dec 3. Mol Cell Endocrinol. 2009. PMID: 19101608 Review.
• Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  Forest MG. Forest MG. Hum Reprod Update. 2004 Nov-Dec;10(6):469-85. doi: 10.1093/humupd/dmh047. Hum Reprod Update. 2004. PMID: 15514016 Review.
• Diagnosis and management of classical congenital adrenal hyperplasia.
  Marumudi E, Khadgawat R, Surana V, Shabir I, Joseph A, Ammini AC. Marumudi E, et al. Steroids. 2013 Aug;78(8):741-6. doi: 10.1016/j.steroids.2013.04.007. Epub 2013 Apr 25. Steroids. 2013. PMID: 23624029

Cited by

• Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
  Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, Flück CE, Guasti L, Huebner A, Kortmann BBM, Krone N, Merke DP, Miller WL, Nordenström A, Reisch N, Sandberg DE, Stikkelbroeck NMML, Touraine P, Utari A, Wudy SA, White PC. Claahsen-van der Grinten HL, et al. Endocr Rev. 2022 Jan 12;43(1):91-159. doi: 10.1210/endrev/bnab016. Endocr Rev. 2022. PMID: 33961029 Free PMC article. Review.
• 46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.
  Baronio F, Ortolano R, Menabò S, Cassio A, Baldazzi L, Di Natale V, Tonti G, Vestrucci B, Balsamo A. Baronio F, et al. Int J Mol Sci. 2019 Sep 17;20(18):4605. doi: 10.3390/ijms20184605. Int J Mol Sci. 2019. PMID: 31533357 Free PMC article. Review.
• Challenges in Prenatal Treatment with Dexamethasone.
  McCann-Crosby B, Placencia FX, Adeyemi-Fowode O, Dietrich J, Franciskovich R, Gunn S, Axelrad M, Tu D, Mann D, Karaviti L, Sutton VR. McCann-Crosby B, et al. Pediatr Endocrinol Rev. 2018 Sep;16(1):186-193. doi: 10.17458/per.vol16.2018.mcpa.dexamethasone. Pediatr Endocrinol Rev. 2018. PMID: 30371037 Free PMC article. Review.
• The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.
  Bird IM, Abbott DH. Bird IM, et al. J Steroid Biochem Mol Biol. 2016 Oct;163:136-46. doi: 10.1016/j.jsbmb.2016.04.021. Epub 2016 May 3. J Steroid Biochem Mol Biol. 2016. PMID: 27154414 Free PMC article. Review.
• Trophoblast Retrieval and Isolation From the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia.
  Bolnick AD, Fritz R, Jain C, Kadam L, Bolnick JM, Kilburn BA, Singh M, Diamond MP, Drewlo S, Armant DR. Bolnick AD, et al. Reprod Sci. 2016 Jun;23(6):717-22. doi: 10.1177/1933719116632922. Epub 2016 Feb 25. Reprod Sci. 2016. PMID: 26919977 Free PMC article.

References

1. 1. J Clin Endocrinol Metab. 2001 Dec;86(12):5651-7 - PubMed
2. 1. J Clin Endocrinol Metab. 2012 Jun;97(6):1881-3 - PubMed
3. 1. Adv Vet Sci Comp Med. 1983;27:99-128 - PubMed
4. 1. Hum Genet. 1992 Mar;88(6):647-8 - PubMed
5. 1. Eur J Endocrinol. 2008 Sep;159(3):309-16 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer
  • Wiley

• Medical

  • Genetic Alliance
  • MedlinePlus Health Information